Loading...
Header Logo
Keywords
Last Name
KP Region

Douglas Allen Corley MD, PhD, MPH

TitleMedical Director, Delivery Science and Applied Research, The Permanente Medical Group,
InstitutionKaiser Permanente Northern California
DepartmentDivision of Research
ORCID ORCID Icon0000-0001-6132-5165 Additional info
vCardDownload vCard
    Other Positions
    TitleResearch Scientist III
    InstitutionKaiser Permanente Northern California
    DepartmentDivision of Research


    Collapse Biography 
    Collapse education and training
    University of California, Berkeley, CABA1987History, Biophysics/Medical Physics (double major)
    University of Pennsylvania, Philadelphia, PAMD1991Medicine
    Brigham & Women's Hospital (Harvard University), Boston, MAResidency1994Internal Medicine
    University of California, San Francisco, CAFellowship1997Gastroenterology
    University of California, San Francisco, CAPhD2002Epidemiology
    Collapse awards and honors
    1991AOA, University of Pennsylvania
    1991Spencer Morris Prize (top medical graduate), University of Pennsylvania
    2008UCSF Clinical Faculty Special Recognition Award (for outstanding contribution to teaching faculty), UCSF
    2015Morris Collen Research Award (Permanente Medical Group, for contribution to science and health of ou, The Permanente Medical Group

    Collapse Overview 
    Collapse overview
    Douglas A. Corley, MD, PhD, MPH, has been a research scientist at the Kaiser Permanente Northern California Division of Research since 2002. He is also a board-certified gastroenterologist who practices at the Kaiser Permanente, San Francisco Medical Center. Dr. Corley’s research interests include outcomes and epidemiologic research in gastroenterology, with a particular emphasis on gastrointestinal cancer epidemiology, cancer surveillance, pharmacoepidemiology, and nutritional epidemiology. Current active research projects include evaluations of Barrett’s esophagus, esophageal adenocarcinoma, gastroesophageal reflux disease, serologic markers for gastrointestinal neoplasia, the long-term effects of gastrointestinal medications (such as anti-acid medications), the intersection between nutrition and gastrointestinal disorders, and the carcinogenic effects of obesity. Dr. Corley is lead investigator for the colon cancer component of the the National Cancer Institute's Population-based Research Optimizing Screening through Personalized Regimens (PROSPR) consortium, a multisite effort to evaluate and improve cancer-screening processes.

    After completing medical school at the University of Pennsylvania, Dr. Corley completed an internal medicine residency at the Brigham & Women’s Hospital of the Harvard Medical School in Boston, Massachusetts; and a gastroenterology fellowship at the University of California, San Francisco (UCSF). Dr. Corley subsequently obtained a master’s degree in public health and a doctorate in epidemiology at the University of California, Berkeley, School of Public Health. Prior to joining the Division of Research, he was on the full-time gastroenterology faculty at UCSF, where he was the chief of the UCSF GI Faculty Practice.

    Collapse Research 
    Collapse research activities and funding
    K08DK002697     (CORLEY, DOUGLAS ALLEN)Mar 1, 2000 - Dec 31, 2005
    NIH/NIDDK
    ETIOLOGIES/SURVEILLANCE OF BARRETT'S ESOPHAGUS
    Role: Principal Investigator

    R03DK058294     (CORLEY, DOUGLAS ALLEN)Sep 1, 2000 - Dec 31, 2002
    NIH/NIDDK
    EVALUATION OF RISK FACTORS FOR BARRETT'S ESOPHAGUS
    Role: Principal Investigator

    R01DK063616     (CORLEY, DOUGLAS ALLEN)Sep 30, 2002 - Jun 30, 2012
    NIH/NIDDK
    Epidemiology and Incidence of Barrett's Esophagus
    Role: Principal Investigator

    R21DK077742     (CORLEY, DOUGLAS ALLEN)May 1, 2008 - Apr 30, 2011
    NIH/NIDDK
    Barrett's Esophagus: Risk Factors in Women
    Role: Principal Investigator

    R56DK087748     (CORLEY, DOUGLAS ALLEN)Sep 1, 2010 - Aug 31, 2012
    NIH/NIDDK
    Adipokines and Barrett's Esophagus
    Role: Principal Investigator

    U54CA163262     (CORLEY, DOUGLAS ALLEN)Sep 1, 2011 - May 31, 2017
    NIH/NCI
    Optimizing Colonoscopy &Fecal Immunochemical Tests for Community-Based Screening
    Role: Principal Investigator

    R01CA206279     (PETERS, ULRIKE)Jan 3, 2017 - Dec 31, 2020
    NIH/NCI
    Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized Screening
    Role: Co-Principal Investigator

    R01CA213645     (DOUBENI, CHYKE ABADAMA)Apr 10, 2017 - Mar 31, 2022
    NIH/NCI
    Effectiveness of screening for colorectal cancer in average risk adults: Colonoscopy vs. FIT
    Role: Co-Principal Investigator

    UM1CA222035     (CORLEY, DOUGLAS ALLEN)Apr 15, 2018 - Mar 31, 2023
    NIH/NCI
    Optimizing Colorectal Cancer Screening PREcision and Outcomes in CommunIty-baSEd Populations (PRECISE)
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Chubak J, McLerran D, Zheng Y, Singal AG, Corley DA, Doria-Rose VP, Doubeni CA, Kamineni A, Haas JS, Halm EA, Skinner CS, Zauber AG, Wernli KJ, Beaber EF. Receipt of Colonoscopy Following Diagnosis of Advanced Adenomas: An Analysis within Integrated Healthcare Delivery Systems. Cancer Epidemiol Biomarkers Prev. 2018 Nov 20. PMID: 30459208.
      View in: PubMed
    2. Bakr O, Zhao W, Corley D. Gastroesophageal Reflux Frequency, Severity, Age of Onset, Family History and Acid Suppressive Therapy Predict Barrett Esophagus in a Large Population. J Clin Gastroenterol. 2018 Nov/Dec; 52(10):873-879. PMID: 29356784.
      View in: PubMed
    3. Kamineni A, Tiro JA, Beaber EF, Silverberg MJ, Wheeler CM, Chao CR, Chubak J, Skinner CS, Corley DA, Kim JJ, Balasubramanian BA, Doria-Rose VP. Cervical Cancer Screening Research in the PROSPR I Consortium: Rationale, Methods, and Baseline Findings from a U.S. Cohort. Int J Cancer. 2018 Oct 24. PMID: 30353911.
      View in: PubMed
    4. Corley DA, Peek RM, Lowe C, Brounstein L, Landis E. Gastroenterology's Improvements and New Features. Gastroenterology. 2018 11; 155(5):1290-1292. PMID: 30300612.
      View in: PubMed
    5. Doubeni CA, Fedewa SA, Levin TR, Jensen CD, Saia C, Zebrowski AM, Quinn VP, Rendle KA, Zauber AG, Becerra-Culqui TA, Mehta SJ, Fletcher RH, Schottinger J, Corley DA. Modifiable Failures in the Colorectal Cancer Screening Process and Their Association with Risk of Death. Gastroenterology. 2018 Sep 27. PMID: 30268788.
      View in: PubMed
    6. Ghai NR, Jensen CD, Corley DA, Doubeni CA, Schottinger JE, Zauber AG, Lee AT, Contreras R, Levin TR, Lee JK, Quinn VP. Colorectal Cancer Screening Participation Among Asian Americans Overall and Subgroups in an Integrated Health Care Setting with Organized Screening. Clin Transl Gastroenterol. 2018 Sep 21; 9(9):186. PMID: 30242160.
      View in: PubMed
    7. Selby K, Jensen CD, Lee JK, Doubeni CA, Schottinger JE, Zhao WK, Chubak J, Halm E, Ghai NR, Contreras R, Skinner C, Kamineni A, Levin TR, Corley DA. Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection: A Community-Based Cohort Study. Ann Intern Med. 2018 Oct 02; 169(7):439-447. PMID: 30242328.
      View in: PubMed
    8. Corley DA, Peek RM. When Should Guidelines Change? A Clarion Call for Evidence Regarding the Benefits and Risks of Screening for Colorectal Cancer at Earlier Ages. Gastroenterology. 2018 10; 155(4):947-949. PMID: 30193780.
      View in: PubMed
    9. Tollivoro TA, Jensen CD, Marks AR, Zhao WK, Schottinger JE, Quinn VP, Ghai NR, Zauber AG, Doubeni CA, Levin TR, Fireman B, Quesenberry CP, Corley DA. Index colonoscopy-related risk factors for postcolonoscopy colorectal cancers. Gastrointest Endosc. 2018 Aug 23. PMID: 30144415.
      View in: PubMed
    10. Kalager M, Wieszczy P, Lansdorp-Vogelaar I, Corley DA, Bretthauer M, Kaminski MF. Overdiagnosis in Colorectal Cancer Screening: Time to Acknowledge a Blind Spot. Gastroenterology. 2018 Sep; 155(3):592-595. PMID: 30076834.
      View in: PubMed
    11. Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, Lee JK, Zhao WK, Udaltsova N, Ghai NR, Lee AT, Quesenberry CP, Fireman BH, Doubeni CA. Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018 11; 155(5):1383-1391.e5. PMID: 30031768.
      View in: PubMed
    12. Callahan CL, Hofmann JN, Corley DA, Zhao WK, Shuch B, Chow WH, Purdue MP. Obesity and renal cell carcinoma risk by histologic subtype: A nested case-control study and meta-analysis. Cancer Epidemiol. 2018 Oct; 56:31-37. PMID: 30029068.
      View in: PubMed
    13. Rutter MD, Beintaris I, Valori R, Chiu HM, Corley DA, Cuatrecasas M, Dekker E, Forsberg A, Gore-Booth J, Haug U, Kaminski MF, Matsuda T, Meijer GA, Morris E, Plumb AA, Rabeneck L, Robertson DJ, Schoen RE, Singh H, Tinmouth J, Young GP, Sanduleanu S. World Endoscopy Organization Consensus Statements on Post-Colonoscopy and Post-Imaging Colorectal Cancer. Gastroenterology. 2018 09; 155(3):909-925.e3. PMID: 29958856.
      View in: PubMed
    14. McMullen C, Bulkley J, Corley DA, Madrid S, Davis AQ, Hesselbrock R, Kurtilla F, Anderson CK, Arterburn D, Somkin CP, Pawloski PA, Ghai NR, Feigelson HS. Health care improvement and survivorship priorities of colorectal cancer survivors: findings from the PORTAL colorectal cancer cohort survey. Support Care Cancer. 2018 Jun 12. PMID: 29948396.
      View in: PubMed
    15. Wang Z, Shaheen NJ, Whiteman DC, Anderson LA, Vaughan TL, Corley DA, El-Serag HB, Rubenstein JH, Thrift AP. Helicobacter pylori Infection Is Associated With Reduced Risk of Barrett's Esophagus: An Analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Am J Gastroenterol. 2018 Aug; 113(8):1148-1155. PMID: 29880962.
      View in: PubMed
    16. Doubeni CA, Gabler NB, Wheeler CM, McCarthy AM, Castle PE, Halm EA, Schnall MD, Skinner CS, Tosteson ANA, Weaver DL, Vachani A, Mehta SJ, Rendle KA, Fedewa SA, Corley DA, Armstrong K. Timely follow-up of positive cancer screening results: A systematic review and recommendations from the PROSPR Consortium. CA Cancer J Clin. 2018 May; 68(3):199-216. PMID: 29603147.
      View in: PubMed
    17. Dong J, Levine DM, Buas MF, Zhang R, Onstad L, Fitzgerald RC, Corley DA, Shaheen NJ, Lagergren J, Hardie LJ, Reid BJ, Iyer PG, Risch HA, Caldas C, Caldas I, Pharoah PD, Liu G, Gammon MD, Chow WH, Bernstein L, Bird NC, Ye W, Wu AH, Anderson LA, MacGregor S, Whiteman DC, Vaughan TL, Thrift AP. Interactions Between Genetic Variants and Environmental Factors Affect Risk of Esophageal Adenocarcinoma and Barrett's Esophagus. Clin Gastroenterol Hepatol. 2018 Oct; 16(10):1598-1606.e4. PMID: 29551738.
      View in: PubMed
    18. Singal AG, Corley DA, Kamineni A, Garcia M, Zheng Y, Doria-Rose PV, Quinn VP, Jensen CD, Chubak J, Tiro J, Doubeni CA, Ghai NR, Skinner CS, Wernli K, Halm EA. Patterns and predictors of repeat fecal immunochemical and occult blood test screening in four large health care systems in the United States. Am J Gastroenterol. 2018 May; 113(5):746-754. PMID: 29487413.
      View in: PubMed
    19. Dong J, Buas MF, Gharahkhani P, Kendall BJ, Onstad L, Zhao S, Anderson LA, Wu AH, Ye W, Bird NC, Bernstein L, Chow WH, Gammon MD, Liu G, Caldas C, Pharoah PD, Risch HA, Iyer PG, Reid BJ, Hardie LJ, Lagergren J, Shaheen NJ, Corley DA, Fitzgerald RC, Whiteman DC, Vaughan TL, Thrift AP. Determining Risk of Barrett's Esophagus and Esophageal Adenocarcinoma Based on Epidemiologic Factors and Genetic Variants. Gastroenterology. 2018 04; 154(5):1273-1281.e3. PMID: 29247777.
      View in: PubMed
    20. Feliciano EMC, Kroenke CH, Meyerhardt JA, Prado CM, Bradshaw PT, Kwan ML, Xiao J, Alexeeff S, Corley D, Weltzien E, Castillo AL, Caan BJ. Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study. JAMA Oncol. 2017 12 01; 3(12):e172319. PMID: 28796857.
      View in: PubMed
    21. Rutter CM, Kim JJ, Meester RGS, Sprague BL, Burger EA, Zauber AG, Ergun MA, Campos NG, Doubeni CA, Trentham-Dietz A, Sy S, Alagoz O, Stout N, Lansdorp-Vogelaar I, Corley DA, Tosteson ANA. Effect of Time to Diagnostic Testing for Breast, Cervical, and Colorectal Cancer Screening Abnormalities on Screening Efficacy: A Modeling Study. Cancer Epidemiol Biomarkers Prev. 2018 02; 27(2):158-164. PMID: 29150480.
      View in: PubMed
    22. Peek RM, Corley DA. The 75th Diamond Anniversary of Gastroenterology: 1943-2018. Gastroenterology. 2018 01; 154(1):1-5. PMID: 29128318.
      View in: PubMed
    23. Selby K, Baumgartner C, Levin TR, Doubeni CA, Zauber AG, Schottinger J, Jensen CD, Lee JK, Corley DA. Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review. Ann Intern Med. 2017 Oct 17; 167(8):565-575. PMID: 29049756.
      View in: PubMed
    24. Suarez-Sarmiento A, Yao X, Hofmann JN, Syed JS, Zhao WK, Purdue MP, Chow WH, Corley D, Shuch B. Ethnic disparities in renal cell carcinoma: An analysis of Hispanic patients in a single-payer healthcare system. Int J Urol. 2017 Oct; 24(10):765-770. PMID: 28913849.
      View in: PubMed
    25. Lee JK, Jensen CD, Levin TR, Zauber AG, Doubeni CA, Zhao WK, Corley DA. Accurate Identification of Colonoscopy Quality and Polyp Findings Using Natural Language Processing. J Clin Gastroenterol. 2017 Sep 12. PMID: 28906424.
      View in: PubMed
    26. Li N, Petrick JL, Steck SE, Bradshaw PT, McClain KM, Niehoff NM, Engel LS, Shaheen NJ, Corley DA, Vaughan TL, Gammon MD. Dietary sugar/starches intake and Barrett's esophagus: a pooled analysis. Eur J Epidemiol. 2017 11; 32(11):1007-1017. PMID: 28864851.
      View in: PubMed
    27. Meester RGS, Doubeni CA, Zauber AG, van Ballegooijen M, Corley DA, Lansdorp-Vogelaar I. Impact of adenoma detection on the benefit of faecal testing vs. colonoscopy for colorectal cancer. Int J Cancer. 2017 12 01; 141(11):2359-2367. PMID: 28815573.
      View in: PubMed
    28. Li D, Woolfrey J, Jiang SF, Jensen CD, Zhao WK, Kakar S, Santamaria M, Rumore G, Armstrong MA, Postlethwaite D, Corley DA, Levin TR. Diagnosis and predictors of sessile serrated adenoma after educational training in a large, community-based, integrated healthcare setting. Gastrointest Endosc. 2018 Mar; 87(3):755-765.e1. PMID: 28843582.
      View in: PubMed
    29. Doubeni CA, Corley DA, Levin TR. Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test. JAMA. 2017 08 01; 318(5):483. PMID: 28763543.
      View in: PubMed
    30. Lo Re V, Carbonari DM, Lewis JD, Roy JA, Corley DA. The Reply. Am J Med. 2017 08; 130(8):e369. PMID: 28734384.
      View in: PubMed
    31. Schneider JL, Corley DA. The Troublesome Epidemiology of Barrett's Esophagus and Esophageal Adenocarcinoma. Gastrointest Endosc Clin N Am. 2017 Jul; 27(3):353-364. PMID: 28577761.
      View in: PubMed
    32. Hillyer GC, Jensen CD, Zhao WK, Neugut AI, Lebwohl B, Tiro JA, Kushi LH, Corley DA. Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 01; 123(19):3744-3753. PMID: 28621809.
      View in: PubMed
    33. Corley DA, Jensen CD, Quinn VP, Doubeni CA, Zauber AG, Lee JK, Schottinger JE, Marks AR, Zhao WK, Ghai NR, Lee AT, Contreras R, Quesenberry CP, Fireman BH, Levin TR. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017 Apr 25; 317(16):1631-1641. PMID: 28444278.
      View in: PubMed
    34. Fedewa SA, Corley DA, Jensen CD, Zhao W, Goodman M, Jemal A, Ward KC, Levin TR, Doubeni CA. Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program. Am J Prev Med. 2017 Sep; 53(3):335-344. PMID: 28427954.
      View in: PubMed
    35. Vogtmann E, Corley DA, Almers LM, Cardwell CR, Murray LJ, Abnet CC. Oral bisphosphonates and colorectal cancer. Sci Rep. 2017 03 10; 7:44177. PMID: 28281559.
      View in: PubMed
    36. Balasubramanian BA, Garcia MP, Corley DA, Doubeni CA, Haas JS, Kamineni A, Quinn VP, Wernli K, Zheng Y, Skinner CS. Racial/ethnic differences in obesity and comorbidities between safety-net- and non safety-net integrated health systems. Medicine (Baltimore). 2017 Mar; 96(11):e6326. PMID: 28296752.
      View in: PubMed
    37. Gowda C, Newcomb CW, Liu Q, Carbonari DM, Lewis JD, Forde KA, Goldberg DS, Reddy KR, Roy JA, Marks AR, Schneider JL, Kostman JR, Tate JP, Lim JK, Justice AC, Goetz MB, Corley DA, Lo Re V. Risk of Acute Liver Injury With Antiretroviral Therapy by Viral Hepatitis Status. Open Forum Infect Dis. 2017; 4(2):ofx012. PMID: 28470014.
      View in: PubMed
    38. Feigelson HS, McMullen CK, Madrid S, Sterrett AT, Powers JD, Blum-Barnett E, Pawloski PA, Ziegenfuss JY, Quinn VP, Arterburn DE, Corley DA. Optimizing patient-reported outcome and risk factor reporting from cancer survivors: a randomized trial of four different survey methods among colorectal cancer survivors. J Cancer Surviv. 2017 Jun; 11(3):393-400. PMID: 28084606.
      View in: PubMed
    39. Cook MB, Coburn SB, Lam JR, Taylor PR, Schneider JL, Corley DA. Cancer incidence and mortality risks in a large US Barrett's oesophagus cohort. Gut. 2018 03; 67(3):418-529. PMID: 28053055.
      View in: PubMed
    40. Levin TR, Corley DA, Jensen CD, Marks AR, Zhao WK, Zebrowski AM, Quinn VP, Browne LW, Taylor WR, Ahlquist DA, Lidgard GP, Berger BM. Genetic Biomarker Prevalence Is Similar in Fecal Immunochemical Test Positive and Negative Colorectal Cancer Tissue. Dig Dis Sci. 2017 03; 62(3):678-688. PMID: 28044229.
      View in: PubMed
    41. Lam JR, Schneider JL, Quesenberry CP, Corley DA. Proton Pump Inhibitor and Histamine-2 Receptor Antagonist Use and Iron Deficiency. Gastroenterology. 2017 03; 152(4):821-829.e1. PMID: 27890768.
      View in: PubMed
    42. Doubeni CA, Jensen CD, Fedewa SA, Quinn VP, Zauber AG, Schottinger JE, Corley DA, Levin TR. Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016 11 12; 29(6):672-681. PMID: 28076249.
      View in: PubMed
    43. Chao C, Silverberg MJ, Becerra TA, Corley DA, Jensen CD, Chen Q, Quinn VP. Human papillomavirus vaccination and subsequent cervical cancer screening in a large integrated healthcare system. Am J Obstet Gynecol. 2017 Feb; 216(2):151.e1-151.e9. PMID: 27746152.
      View in: PubMed
    44. Doubeni CA, Corley DA, Quinn VP, Jensen CD, Zauber AG, Goodman M, Johnson JR, Mehta SJ, Becerra TA, Zhao WK, Schottinger J, Doria-Rose VP, Levin TR, Weiss NS, Fletcher RH. Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: a large community-based study. Gut. 2018 02; 67(2):291-298. PMID: 27733426.
      View in: PubMed
    45. Lee A, Jensen CD, Marks AR, Zhao WK, Doubeni CA, Zauber AG, Quinn VP, Levin TR, Corley DA. Endoscopist fatigue estimates and colonoscopic adenoma detection in a large community-based setting. Gastrointest Endosc. 2017 Mar; 85(3):601-610.e2. PMID: 27702568.
      View in: PubMed
    46. Thrift AP, Anderson LA, Murray LJ, Cook MB, Shaheen NJ, Rubenstein JH, El-Serag HB, Vaughan TL, Schneider JL, Whiteman DC, Corley DA. Nonsteroidal Anti-Inflammatory Drug Use is Not Associated With Reduced Risk of Barrett's Esophagus. Am J Gastroenterol. 2016 11; 111(11):1528-1535. PMID: 27575711.
      View in: PubMed
    47. Gharahkhani P, Fitzgerald RC, Vaughan TL, Palles C, Gockel I, Tomlinson I, Buas MF, May A, Gerges C, Anders M, Becker J, Kreuser N, Noder T, Venerito M, Veits L, Schmidt T, Manner H, Schmidt C, Hess T, Böhmer AC, Izbicki JR, Hölscher AH, Lang H, Lorenz D, Schumacher B, Hackelsberger A, Mayershofer R, Pech O, Vashist Y, Ott K, Vieth M, Weismüller J, Nöthen MM, Attwood S, Barr H, Chegwidden L, de Caestecker J, Harrison R, Love SB, MacDonald D, Moayyedi P, Prenen H, Watson RGP, Iyer PG, Anderson LA, Bernstein L, Chow WH, Hardie LJ, Lagergren J, Liu G, Risch HA, Wu AH, Ye W, Bird NC, Shaheen NJ, Gammon MD, Corley DA, Caldas C, Moebus S, Knapp M, Peters WHM, Neuhaus H, Rösch T, Ell C, MacGregor S, Pharoah P, Whiteman DC, Jankowski J, Schumacher J. Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. Lancet Oncol. 2016 Oct; 17(10):1363-1373. PMID: 27527254.
      View in: PubMed
    48. Dai JY, Tapsoba Jde D, Buas MF, Risch HA, Vaughan TL. Constrained Score Statistics Identify Genetic Variants Interacting with Multiple Risk Factors in Barrett's Esophagus. Am J Hum Genet. 2016 08 04; 99(2):352-65. PMID: 27486777.
      View in: PubMed
    49. Buas MF, He Q, Johnson LG, Onstad L, Levine DM, Thrift AP, Gharahkhani P, Palles C, Lagergren J, Fitzgerald RC, Ye W, Caldas C, Bird NC, Shaheen NJ, Bernstein L, Gammon MD, Wu AH, Hardie LJ, Pharoah PD, Liu G, Iyer P, Corley DA, Risch HA, Chow WH, Prenen H, Chegwidden L, Love S, Attwood S, Moayyedi P, MacDonald D, Harrison R, Watson P, Barr H, deCaestecker J, Tomlinson I, Jankowski J, Whiteman DC, MacGregor S, Vaughan TL, Madeleine MM. Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. Gut. 2017 10; 66(10):1739-1747. PMID: 27486097.
      View in: PubMed
    50. Mehta SJ, Jensen CD, Quinn VP, Schottinger JE, Zauber AG, Meester R, Laiyemo AO, Fedewa S, Goodman M, Fletcher RH, Levin TR, Corley DA, Doubeni CA. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med. 2016 11; 31(11):1323-1330. PMID: 27412426.
      View in: PubMed
    51. Wennerström EC, Risques RA, Prunkard D, Giffen C, Corley DA, Murray LJ, Whiteman DC, Wu AH, Bernstein L, Ye W, Chow WH, Vaughan TL, Liao LM. Leukocyte telomere length in relation to the risk of Barrett's esophagus and esophageal adenocarcinoma. Cancer Med. 2016 09; 5(9):2657-65. PMID: 27384379.
      View in: PubMed
    52. Klabunde CN, Zheng Y, Quinn VP, Beaber EF, Rutter CM, Halm EA, Chubak J, Doubeni CA, Haas JS, Kamineni A, Schapira MM, Vacek PM, Garcia MP, Corley DA. Influence of Age and Comorbidity on Colorectal Cancer Screening in the Elderly. Am J Prev Med. 2016 09; 51(3):e67-75. PMID: 27344108.
      View in: PubMed
    53. Halm EA, Beaber EF, McLerran D, Chubak J, Corley DA, Rutter CM, Doubeni CA, Haas JS, Balasubramanian BA. Association Between Primary Care Visits and Colorectal Cancer Screening Outcomes in the Era of Population Health Outreach. J Gen Intern Med. 2016 10; 31(10):1190-7. PMID: 27279097.
      View in: PubMed
    54. Kendall BJ, Rubenstein JH, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Shaheen NJ, Corley DA, Chandar AK, Li L, Greer KB, Chak A, El-Serag HB, Whiteman DC, Thrift AP. Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol. 2016 10; 14(10):1412-1419.e3. PMID: 27264393.
      View in: PubMed
    55. Mafolasire A, Yao X, Nawaf C, Suarez-Sarmiento A, Chow WH, Zhao W, Corley D, Hofmann JN, Purdue M, Adeniran AJ, Shuch B. Racial disparities in renal cell carcinoma: a single-payer healthcare experience. Cancer Med. 2016 08; 5(8):2101-8. PMID: 27228559.
      View in: PubMed
    56. Corley DA, Peek RM. The Dawning of a New Editorial Board for Gastroenterology. Gastroenterology. 2016 07; 151(1):4-8. PMID: 27215655.
      View in: PubMed
    57. Meester RG, Zauber AG, Doubeni CA, Jensen CD, Quinn VP, Helfand M, Dominitz JA, Levin TR, Corley DA, Lansdorp-Vogelaar I. Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test. Clin Gastroenterol Hepatol. 2016 10; 14(10):1445-1451.e8. PMID: 27211498.
      View in: PubMed
    58. Corley DA, Haas JS, Kobrin S. Reducing Variation in the "Standard of Care" for Cancer Screening: Recommendations From the PROSPR Consortium. JAMA. 2016 May 17; 315(19):2067-8. PMID: 27089237; PMCID: PMC4920648.
    59. McCarthy AM, Kim JJ, Beaber EF, Zheng Y, Burnett-Hartman A, Chubak J, Ghai NR, McLerran D, Breen N, Conant EF, Geller BM, Green BB, Klabunde CN, Inrig S, Skinner CS, Quinn VP, Haas JS, Schnall M, Rutter CM, Barlow WE, Corley DA, Armstrong K, Doubeni CA. Follow-Up of Abnormal Breast and Colorectal Cancer Screening by Race/Ethnicity. Am J Prev Med. 2016 10; 51(4):507-12. PMID: 27132628.
      View in: PubMed
    60. Burnett-Hartman AN, Mehta SJ, Zheng Y, Ghai NR, McLerran DF, Chubak J, Quinn VP, Skinner CS, Corley DA, Inadomi JM, Doubeni CA. Racial/Ethnic Disparities in Colorectal Cancer Screening Across Healthcare Systems. Am J Prev Med. 2016 10; 51(4):e107-15. PMID: 27050413.
      View in: PubMed
    61. Tosteson AN, Beaber EF, Tiro J, Kim J, McCarthy AM, Quinn VP, Doria-Rose VP, Wheeler CM, Barlow WE, Bronson M, Garcia M, Corley DA, Haas JS, Halm EA, Kamineni A, Rutter CM, Tosteson TD, Trentham-Dietz A, Weaver DL. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium. J Gen Intern Med. 2016 Apr; 31(4):372-9. PMID: 26658934.
      View in: PubMed
    62. Doubeni CA, Corley DA, Zauber AG. Colorectal Cancer Health Disparities and the Role of US Law and Health Policy. Gastroenterology. 2016 05; 150(5):1052-1055. PMID: 27016715.
      View in: PubMed
    63. Lo Re V, Forde KA, Lewis JD, Goldberg DS, Carbonari DM, Roy J, Reddy KR, Sha D, Strom BL, Corley DA. Reply. Clin Gastroenterol Hepatol. 2016 06; 14(6):918-919. PMID: 26883072.
      View in: PubMed
    64. Chubak J, Garcia MP, Burnett-Hartman AN, Zheng Y, Corley DA, Halm EA, Singal AG, Klabunde CN, Doubeni CA, Kamineni A, Levin TR, Schottinger JE, Green BB, Quinn VP, Rutter CM. Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50. PMID: 26843520; PMCID: PMC4767632 [Available on 02/01/17].
    65. Jensen CD, Corley DA, Quinn VP, Doubeni CA, Zauber AG, Lee JK, Zhao WK, Marks AR, Schottinger JE, Ghai NR, Lee AT, Contreras R, Klabunde CN, Quesenberry CP, Levin TR, Mysliwiec PA. Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med. 2016 Apr 05; 164(7):456-63. PMID: 26811150; PMCID: PMC4973858 [Available on 04/05/17].
    66. Lee JK, Corley DA. What makes a "good" colonoscopy quality indicator? Gastrointest Endosc. 2016 Jan; 83(1):179-81. PMID: 26706304.
      View in: PubMed
    67. Lo Re V, Carbonari DM, Lewis JD, Forde KA, Goldberg DS, Reddy KR, Haynes K, Roy JA, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA. Oral Azole Antifungal Medications and Risk of Acute Liver Injury, Overall and by Chronic Liver Disease Status. Am J Med. 2016 Mar; 129(3):283-91.e5. PMID: 26597673.
      View in: PubMed
    68. Schneider JL, Kolitsopoulos F, Corley DA. Risk of gastric cancer, gastrointestinal cancers and other cancers: a comparison of treatment with pantoprazole and other proton pump inhibitors. Aliment Pharmacol Ther. 2016 Jan; 43(1):73-82. PMID: 26541643.
      View in: PubMed
    69. Vogtmann E, Corley DA, Almers LM, Cardwell CR, Murray LJ, Abnet CC. Oral Bisphosphonate Exposure and the Risk of Upper Gastrointestinal Cancers. PLoS One. 2015; 10(10):e0140180. PMID: 26445463; PMCID: PMC4596624.
    70. Ek WE, Lagergren K, Cook M, Wu AH, Abnet CC, Levine D, Chow WH, Bernstein L, Risch HA, Shaheen NJ, Bird NC, Corley DA, Hardie LJ, Fitzgerald RC, Gammon MD, Romero Y, Liu G, Ye W, Vaughan TL, MacGregor S, Whiteman DC, Westberg L, Lagergren J. Polymorphisms in genes in the androgen pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. Int J Cancer. 2016 Mar 01; 138(5):1146-52. PMID: 26414697.
      View in: PubMed
    71. Lagergren K, Ek WE, Levine D, Chow WH, Bernstein L, Casson AG, Risch HA, Shaheen NJ, Bird NC, Reid BJ, Corley DA, Hardie LJ, Wu AH, Fitzgerald RC, Pharoah P, Caldas C, Romero Y, Vaughan TL, MacGregor S, Whiteman D, Westberg L, Nyren O, Lagergren J. Polymorphisms in Genes of Relevance for Oestrogen and Oxytocin Pathways and Risk of Barrett's Oesophagus and Oesophageal Adenocarcinoma: A Pooled Analysis from the BEACON Consortium. PLoS One. 2015; 10(9):e0138738. PMID: 26406593.
      View in: PubMed
    72. Thomas SJ, Almers L, Schneider J, Graham JE, Havel PJ, Corley DA. Ghrelin and Leptin Have a Complex Relationship with Risk of Barrett's Esophagus. Dig Dis Sci. 2016 Jan; 61(1):70-9. PMID: 26396004.
      View in: PubMed
    73. Dai JY, de Dieu Tapsoba J, Buas MF, Onstad LE, Levine DM, Risch HA, Chow WH, Bernstein L, Ye W, Lagergren J, Bird NC, Corley DA, Shaheen NJ, Wu AH, Reid BJ, Hardie LJ, Whiteman DC, Vaughan TL. A newly identified susceptibility locus near FOXP1 modifies the association of gastroesophageal reflux with Barrett's esophagus. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1739-47. PMID: 26377193.
      View in: PubMed
    74. Marks AR, Pietrofesa RA, Jensen CD, Zebrowski A, Corley DA, Doubeni CA. Metformin use and risk of colorectal adenoma after polypectomy in patients with type 2 diabetes mellitus. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1692-8. PMID: 26377195; PMCID: PMC4633388 [Available on 11/01/16].
    75. Lee E, Stram DO, Ek WE, Onstad LE, MacGregor S, Gharahkhani P, Ye W, Lagergren J, Shaheen NJ, Murray LJ, Hardie LJ, Gammon MD, Chow WH, Risch HA, Corley DA, Levine DM, Whiteman DC, Bernstein L, Bird NC, Vaughan TL, Wu AH. Pleiotropic analysis of cancer risk loci on esophageal adenocarcinoma risk. Cancer Epidemiol Biomarkers Prev. 2015 Nov; 24(11):1801-3. PMID: 26364162.
      View in: PubMed
    76. Atkins L, Hunkeler EM, Jensen CD, Michie S, Lee JK, Doubeni CA, Zauber AG, Levin TR, Quinn VP, Corley DA. Factors influencing variation in physician adenoma detection rates: a theory-based approach for performance improvement. Gastrointest Endosc. 2016 Mar; 83(3):617-26.e2. PMID: 26366787; PMCID: PMC4762744 [Available on 03/01/17].
    77. Sharma P, Katzka DA, Gupta N, Ajani J, Buttar N, Chak A, Corley D, El-Serag H, Falk GW, Fitzgerald R, Goldblum J, Gress F, Ilson DH, Inadomi JM, Kuipers EJ, Lynch JP, McKeon F, Metz D, Pasricha PJ, Pech O, Peek R, Peters JH, Repici A, Seewald S, Shaheen NJ, Souza RF, Spechler SJ, Vennalaganti P, Wang K. Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. Gastroenterology. 2015 Nov; 149(6):1599-606. PMID: 26296479; PMCID: PMC4820399.
    78. Goodman M, Fletcher RH, Doria-Rose VP, Jensen CD, Zebrowski AM, Becerra TA, Quinn VP, Zauber AG, Corley DA, Doubeni CA. Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res. 2015 Nov; 4(6):541-51. PMID: 26201973; PMCID: PMC4666780.
    79. Hofmann JN, Corley DA, Colt JS, Shuch B, Chow WH, Purdue MP. The authors respond. Epidemiology. 2015 Jul; 26(4):e49. PMID: 25899997.
      View in: PubMed
    80. Lo Re V, Haynes K, Forde KA, Goldberg DS, Lewis JD, Carbonari DM, Leidl KB, Reddy KR, Nezamzadeh MS, Roy J, Sha D, Marks AR, De Boer J, Schneider JL, Strom BL, Corley DA. Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2360-8. PMID: 26122767.
      View in: PubMed
    81. Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Jensen CD, van der Meulen MP, Levin TR, Quinn VP, Schottinger JE, Zauber AG, Corley DA, van Ballegooijen M. Variation in Adenoma Detection Rate and the Lifetime Benefits and Cost of Colorectal Cancer Screening: A Microsimulation Model. JAMA. 2015 Jun 16; 313(23):2349-58. PMID: 26080339; PMCID: PMC4631392.
    82. Buas MF, Onstad L, Levine DM, Risch HA, Chow WH, Liu G, Fitzgerald RC, Bernstein L, Ye W, Bird NC, Romero Y, Casson AG, Corley DA, Shaheen NJ, Wu AH, Gammon MD, Reid BJ, Hardie LJ, Peters U, Whiteman DC, Vaughan TL. MiRNA-Related SNPs and Risk of Esophageal Adenocarcinoma and Barrett's Esophagus: Post Genome-Wide Association Analysis in the BEACON Consortium. PLoS One. 2015; 10(6):e0128617. PMID: 26039359; PMCID: PMC4454432.
    83. Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Brian Fennerty M, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J. Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 Jun; 110(6):943. PMID: 26052782.
      View in: PubMed
    84. Beaber EF, Kim JJ, Schapira MM, Tosteson AN, Zauber AG, Geiger AM, Kamineni A, Weaver DL, Tiro JA. Unifying screening processes within the PROSPR consortium: a conceptual model for breast, cervical, and colorectal cancer screening. J Natl Cancer Inst. 2015 Jun; 107(6):djv120. PMID: 25957378; PMCID: PMC4838064.
    85. Corley DA, Feigelson HS, Lieu TA, McGlynn EA. Building Data Infrastructure to Evaluate and Improve Quality: PCORnet. J Oncol Pract. 2015 May; 11(3):204-6. PMID: 25980016; PMCID: PMC4438109.
    86. Bennett C, Moayyedi P, Corley DA, DeCaestecker J, Falck-Ytter Y, Falk G, Vakil N, Sanders S, Vieth M, Inadomi J, Aldulaimi D, Ho KY, Odze R, Meltzer SJ, Quigley E, Gittens S, Watson P, Zaninotto G, Iyer PG, Alexandre L, Ang Y, Callaghan J, Harrison R, Singh R, Bhandari P, Bisschops R, Geramizadeh B, Kaye P, Krishnadath S, Fennerty MB, Manner H, Nason KS, Pech O, Konda V, Ragunath K, Rahman I, Romero Y, Sampliner R, Siersema PD, Tack J, Tham TC, Trudgill N, Weinberg DS, Wang J, Wang K, Wong JY, Attwood S, Malfertheiner P, MacDonald D, Barr H, Ferguson MK, Jankowski J. BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. Am J Gastroenterol. 2015 May; 110(5):662-82; quiz 683. PMID: 25869390; PMCID: PMC4436697.
    87. Lo Re V, Carbonari DM, Forde KA, Goldberg D, Lewis JD, Haynes K, Leidl KB, Reddy RK, Roy J, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA. Validity of diagnostic codes and laboratory tests of liver dysfunction to identify acute liver failure events. Pharmacoepidemiol Drug Saf. 2015 Jul; 24(7):676-83. PMID: 25866286; PMCID: PMC4509617.
    88. Corley DA, Schuppan D. Food, the immune system, and the gastrointestinal tract. Gastroenterology. 2015 May; 148(6):1083-6. PMID: 25835098; PMCID: PMC4409565.
    89. Meester RG, Doubeni CA, Zauber AG, Goede SL, Levin TR, Corley DA, Jemal A, Lansdorp-Vogelaar I. Public health impact of achieving 80% colorectal cancer screening rates in the United States by 2018. Cancer. 2015 Jul 01; 121(13):2281-5. PMID: 25763558; PMCID: PMC4567966.
    90. Goldberg DS, Forde KA, Carbonari DM, Lewis JD, Leidl KB, Reddy KR, Haynes K, Roy J, Sha D, Marks AR, Schneider JL, Strom BL, Corley DA, Lo Re V. Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system. Gastroenterology. 2015 Jun; 148(7):1353-61.e3. PMID: 25733099.
      View in: PubMed
    91. Abnet CC, Corley DA, Freedman ND, Kamangar F. Diet and upper gastrointestinal malignancies. Gastroenterology. 2015 May; 148(6):1234-1243.e4. PMID: 25680671.
      View in: PubMed
    92. Hoffmann TJ, Sakoda LC, Shen L, Jorgenson E, Habel LA, Liu J, Kvale MN, Asgari MM, Banda Y, Corley D, Kushi LH, Quesenberry CP, Schaefer C, Van Den Eeden SK, Risch N, Witte JS. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930. PMID: 25629170; PMCID: PMC4309593.
    93. Almers LM, Graham JE, Havel PJ, Corley DA. Adiponectin May Modify the Risk of Barrett's Esophagus in Patients With Gastroesophageal Reflux Disease. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2256-64.e1-3. PMID: 25632808; PMCID: PMC4515407 [Available on 12/01/16].
    94. Lee JK, Jensen CD, Lee A, Doubeni CA, Zauber AG, Levin TR, Zhao WK, Corley DA. Development and validation of an algorithm for classifying colonoscopy indication. Gastrointest Endosc. 2015 Mar; 81(3):575-582.e4. PMID: 25577596; PMCID: PMC4340717.
    95. Hofmann JN, Corley DA, Zhao WK, Colt JS, Shuch B, Chow WH, Purdue MP. Chronic kidney disease and risk of renal cell carcinoma: differences by race. Epidemiology. 2015 Jan; 26(1):59-67. PMID: 25393631.
      View in: PubMed
    96. Corley D, Silverberg MJ. Does Human Papillomavirus Cause Esophageal Adenocarcinoma? Clin Gastroenterol Hepatol. 2015 Jul; 13(7):1369-70. PMID: 25543103.
      View in: PubMed
    97. Meester RG, Doubeni CA, Lansdorp-Vogelaar I, Goede SL, Levin TR, Quinn VP, Ballegooijen Mv, Corley DA, Zauber AG. Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol. 2015 Mar; 25(3):208-213.e1. PMID: 25721748; PMCID: PMC4554530.
    98. Schneider JL, Corley DA. A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma. Best Pract Res Clin Gastroenterol. 2015 Feb; 29(1):29-39. PMID: 25743454.
      View in: PubMed
    99. Singal AG, Gupta S, Lee J, Halm EA, Rutter CM, Corley D, Inadomi J. Importance of determining indication for colonoscopy: implications for practice and policy original. Clin Gastroenterol Hepatol. 2014 Dec; 12(12):1958-63.e1-3. PMID: 25606584; PMCID: PMC4303343.
    100. Kubo A, Shlager L, Corley DA. Vertical transmission of hepatitis B virus--in response. Ann Intern Med. 2014 Nov 18; 161(10):763. PMID: 25402525.
      View in: PubMed
    101. Palles C, Chegwidden L, Li X, Findlay JM, Farnham G, Castro Giner F, Peppelenbosch MP, Kovac M, Adams CL, Prenen H, Briggs S, Harrison R, Sanders S, MacDonald D, Haigh C, Tucker A, Love S, Nanji M, deCaestecker J, Ferry D, Rathbone B, Hapeshi J, Barr H, Moayyedi P, Watson P, Zietek B, Maroo N, Gay L, Underwood T, Boulter L, McMurtry H, Monk D, Patel P, Ragunath K, Al Dulaimi D, Murray I, Koss K, Veitch A, Trudgill N, Nwokolo C, Rembacken B, Atherfold P, Green E, Ang Y, Kuipers EJ, Chow W, Paterson S, Kadri S, Beales I, Grimley C, Mullins P, Beckett C, Farrant M, Dixon A, Kelly S, Johnson M, Wajed S, Dhar A, Sawyer E, Roylance R, Onstad L, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Reid BJ, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Fitzgerald R, Whiteman DC, Risch HA, Levine DM, Vaughan TL, Verhaar AP, van den Brande J, Toxopeus EL, Spaander MC, Wijnhoven BP, van der Laan LJ, Krishnadath K, Wijmenga C, Trynka G, McManus R, Reynolds JV, O'Sullivan J, MacMathuna P, McGarrigle SA, Kelleher D, Vermeire S, Cleynen I, Bisschops R, Tomlinson I, Jankowski J. Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus. Gastroenterology. 2015 Feb; 148(2):367-78. PMID: 25447851; PMCID: PMC4315134.
    102. Hillyer GC, Lebwohl B, Rosenberg RM, Neugut AI, Wolf R, Basch CH, Mata J, Hernandez E, Corley DA, Shea S, Basch CE. Assessing bowel preparation quality using the mean number of adenomas per colonoscopy. Therap Adv Gastroenterol. 2014 Nov; 7(6):238-46. PMID: 25364383; PMCID: PMC4212469.
    103. Jensen CD, Doubeni CA, Quinn VP, Levin TR, Zauber AG, Schottinger JE, Marks AR, Zhao WK, Lee JK, Ghai NR, Schneider JL, Fireman BH, Quesenberry CP, Corley DA. Adjusting for patient demographics has minimal effects on rates of adenoma detection in a large, community-based setting. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):739-46. PMID: 25445767; PMCID: PMC4369190.
    104. Buas MF, Levine DM, Makar KW, Utsugi H, Onstad L, Li X, Galipeau PC, Shaheen NJ, Hardie LJ, Romero Y, Bernstein L, Gammon MD, Casson AG, Bird NC, Risch HA, Ye W, Liu G, Corley DA, Blount PL, Fitzgerald RC, Whiteman DC, Wu AH, Reid BJ, Vaughan TL. Integrative post-genome-wide association analysis of CDKN2A and TP53 SNPs and risk of esophageal adenocarcinoma. Carcinogenesis. 2014 Dec; 35(12):2740-7. PMID: 25280564; PMCID: PMC4247522.
    105. Thrift AP, Shaheen NJ, Gammon MD, Bernstein L, Reid BJ, Onstad L, Risch HA, Liu G, Bird NC, Wu AH, Corley DA, Romero Y, Chanock SJ, Chow WH, Casson AG, Levine DM, Zhang R, Ek WE, MacGregor S, Ye W, Hardie LJ, Vaughan TL, Whiteman DC. Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study. J Natl Cancer Inst. 2014 Nov; 106(11). PMID: 25269698; PMCID: PMC4200028.
    106. Schneider JL, Zhao WK, Corley DA. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of Barrett's esophagus. Dig Dis Sci. 2015 Feb; 60(2):436-43. PMID: 25213077; PMCID: PMC4304909.
    107. Kubo A, Block G, Quesenberry CP, Buffler P, Corley DA. Dietary guideline adherence for gastroesophageal reflux disease. BMC Gastroenterol. 2014 Aug 14; 14:144. PMID: 25125219; PMCID: PMC4139138.
    108. Cook MB, Corley DA, Murray LJ, Liao LM, Kamangar F, Ye W, Gammon MD, Risch HA, Casson AG, Freedman ND, Chow WH, Wu AH, Bernstein L, Nyrén O, Pandeya N, Whiteman DC, Vaughan TL. Gastroesophageal reflux in relation to adenocarcinomas of the esophagus: a pooled analysis from the Barrett's and Esophageal Adenocarcinoma Consortium (BEACON). PLoS One. 2014; 9(7):e103508. PMID: 25075959; PMCID: PMC4116205.
    109. Thrift AP, Cook MB, Vaughan TL, Anderson LA, Murray LJ, Whiteman DC, Shaheen NJ, Corley DA. Alcohol and the risk of Barrett's esophagus: a pooled analysis from the International BEACON Consortium. Am J Gastroenterol. 2014 Oct; 109(10):1586-94. PMID: 25047401.
      View in: PubMed
    110. Lee JK, Terdiman JP, Corley DA. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014 07 10; 371(2):186. PMID: 25006739.
      View in: PubMed
    111. Corley DA, Levin TR, Doubeni CA. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 06 26; 370(26):2541. PMID: 24963577.
      View in: PubMed
    112. Lu Y, Ek WE, Whiteman D, Vaughan TL, Spurdle AB, Easton DF, Pharoah PD, Thompson DJ, Dunning AM, Hayward NK, Chenevix-Trench G, Macgregor S. Most common 'sporadic' cancers have a significant germline genetic component. Hum Mol Genet. 2014 Nov 15; 23(22):6112-8. PMID: 24943595; PMCID: PMC4271103.
    113. Kubo A, Shlager L, Marks AR, Lakritz D, Beaumont C, Gabellini K, Corley DA. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med. 2014 Jun 17; 160(12):828-35. PMID: 24862434; PMCID: PMC4086733.
    114. Tiro JA, Kamineni A, Levin TR, Zheng Y, Schottinger JS, Rutter CM, Corley DA, Skinner CS, Chubak J, Doubeni CA, Halm EA, Gupta S, Wernli KJ, Klabunde C. The colorectal cancer screening process in community settings: a conceptual model for the population-based research optimizing screening through personalized regimens consortium. Cancer Epidemiol Biomarkers Prev. 2014 Jul; 23(7):1147-58. PMID: 24917182; PMCID: PMC4148641.
    115. McGlynn EA, Lieu TA, Durham ML, Bauck A, Laws R, Go AS, Chen J, Feigelson HS, Corley DA, Young DR, Nelson AF, Davidson AJ, Morales LS, Kahn MG. Developing a data infrastructure for a learning health system: the PORTAL network. J Am Med Inform Assoc. 2014 Jul-Aug; 21(4):596-601. PMID: 24821738; PMCID: PMC4078291.
    116. Corley D, Lam J, Schneider J. Gastric acid-inhibiting medications and vitamin B12 deficiency--reply. JAMA. 2014 Apr 09; 311(14):1445-6. PMID: 24715080.
      View in: PubMed
    117. Corley DA, Jensen CD, Marks AR, Zhao WK, Lee JK, Doubeni CA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry CP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med. 2014 Apr 03; 370(14):1298-306. PMID: 24693890; PMCID: PMC4036494.
    118. Fassil H, Adams KF, Weinmann S, Doria-Rose VP, Johnson E, Williams AE, Corley DA, Doubeni CA. Approaches for classifying the indications for colonoscopy using detailed clinical data. BMC Cancer. 2014 Feb 15; 14:95. PMID: 24529031; PMCID: PMC3927818.
    119. Thrift AP, Risch HA, Onstad L, Shaheen NJ, Casson AG, Bernstein L, Corley DA, Levine DM, Chow WH, Reid BJ, Romero Y, Hardie LJ, Liu G, Wu AH, Bird NC, Gammon MD, Ye W, Whiteman DC, Vaughan TL. Risk of esophageal adenocarcinoma decreases with height, based on consortium analysis and confirmed by Mendelian randomization. Clin Gastroenterol Hepatol. 2014 Oct; 12(10):1667-76.e1. PMID: 24530603.
      View in: PubMed
    120. Lee JK, Liles EG, Bent S, Levin TR, Corley DA. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014 Feb 04; 160(3):171. PMID: 24658694; PMCID: PMC4189821.
    121. Corley DA. Reply: To PMID 23673354. Gastroenterology. 2014 Feb; 146(2):588-9. PMID: 24361430.
      View in: PubMed
    122. Lam JR, Schneider JL, Zhao W, Corley DA. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013 Dec 11; 310(22):2435-42. PMID: 24327038.
      View in: PubMed
    123. Yuhara H, Corley DA, Nakahara F, Nakajima T, Koike J, Igarashi M, Suauki T, Mine T. Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis. J Gastroenterol. 2014 Jun; 49(6):992-1000. PMID: 24221694.
      View in: PubMed
    124. Ek WE, Levine DM, D'Amato M, Pedersen NL, Magnusson PK, Bresso F, Onstad LE, Schmidt PT, Törnblom H, Nordenstedt H, Romero Y, Chow WH, Murray LJ, Gammon MD, Liu G, Bernstein L, Casson AG, Risch HA, Shaheen NJ, Bird NC, Reid BJ, Corley DA, Hardie LJ, Ye W, Wu AH, Zucchelli M, Spector TD, Hysi P, Vaughan TL, Whiteman DC, MacGregor S. Germline genetic contributions to risk for esophageal adenocarcinoma, Barrett's esophagus, and gastroesophageal reflux. J Natl Cancer Inst. 2013 Nov 20; 105(22):1711-8. PMID: 24168968; PMCID: PMC3833931.
    125. Eldridge RC, Doubeni CA, Fletcher RH, Zauber AG, Corley DA, Doria-Rose VP, Goodman M. Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy. J Med Screen. 2013 Dec; 20(4):198-207. PMID: 24144847; PMCID: PMC3923570.
    126. Levine DM, Ek WE, Zhang R, Liu X, Onstad L, Sather C, Lao-Sirieix P, Gammon MD, Corley DA, Shaheen NJ, Bird NC, Hardie LJ, Murray LJ, Reid BJ, Chow WH, Risch HA, Nyrén O, Ye W, Liu G, Romero Y, Bernstein L, Wu AH, Casson AG, Chanock SJ, Harrington P, Caldas I, Debiram-Beecham I, Caldas C, Hayward NK, Pharoah PD, Fitzgerald RC, Macgregor S, Whiteman DC, Vaughan TL. A genome-wide association study identifies new susceptibility loci for esophageal adenocarcinoma and Barrett's esophagus. Nat Genet. 2013 Dec; 45(12):1487-93. PMID: 24121790; PMCID: PMC3840115.
    127. Levin TR, Corley DA. Colorectal-cancer screening--coming of age. N Engl J Med. 2013 Sep 19; 369(12):1164-6. PMID: 24047066.
      View in: PubMed
    128. Corley DA. Can You Stop Surveillance After Radiofrequency Ablation of Barrett's Esophagus? A Glass Half Full. Gastroenterology. 2013 Jul; 145(1):39-42. PMID: 23727498.
      View in: PubMed
    129. Corley DA, Mehtani K, Quesenberry C, Zhao W, de Boer J, Weiss NS. Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas. Gastroenterology. 2013 Aug; 145(2):312-9.e1. PMID: 23673354; PMCID: PMC3767470.
    130. Coleman HG, Murray LJ, Hicks B, Bhat SK, Kubo A, Corley DA, Cardwell CR, Cantwell MM. Dietary fiber and the risk of precancerous lesions and cancer of the esophagus: a systematic review and meta-analysis. Nutr Rev. 2013 Jul; 71(7):474-82. PMID: 23815145.
      View in: PubMed
    131. Yuhara H, Steinmaus C, Corley D, Koike J, Igarashi M, Suzuki T, Mine T. Meta-analysis: the risk of venous thromboembolism in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2013 May; 37(10):953-62. PMID: 23550660.
      View in: PubMed
    132. Doubeni CA, Weinmann S, Adams K, Kamineni A, Buist DS, Ash AS, Rutter CM, Doria-Rose VP, Corley DA, Greenlee RT, Chubak J, Williams A, Kroll-Desrosiers AR, Johnson E, Webster J, Richert-Boe K, Levin TR, Fletcher RH, Weiss NS. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med. 2013 Mar 05; 158(5 Pt 1):312-20. PMID: 23460054; PMCID: PMC3752391.
    133. Lee JK, Levin TR, Corley DA. The road ahead: what if gastroenterologists were accountable for preventing colorectal cancer? Clin Gastroenterol Hepatol. 2013 Mar; 11(3):204-7. PMID: 23432901.
      View in: PubMed
    134. Kubo A, Cook MB, Shaheen NJ, Vaughan TL, Whiteman DC, Murray L, Corley DA. Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium. Gut. 2013 Dec; 62(12):1684-91. PMID: 23355549.
      View in: PubMed
    135. Hoyo C, Cook MB, Kamangar F, Freedman ND, Whiteman DC, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Wu AH, Ward MH, Casson AG, Murray LJ, Corley DA, Nyrén O, Pandeya N, Vaughan TL, Chow WH, Gammon MD. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the International BEACON Consortium. Int J Epidemiol. 2012 Dec; 41(6):1706-18. PMID: 23148106; PMCID: PMC3535758.
    136. Corley DA, Jensen CD, Marks AR, Zhao WK, de Boer J, Levin TR, Doubeni C, Fireman BH, Quesenberry CP. Variation of adenoma prevalence by age, sex, race, and colon location in a large population: implications for screening and quality programs. Clin Gastroenterol Hepatol. 2013 Feb; 11(2):172-80. PMID: 22985608; PMCID: PMC3954741.
    137. Su Z, Gay LJ, Strange A, Palles C, Band G, Whiteman DC, Lescai F, Langford C, Nanji M, Edkins S, van der Winkel A, Levine D, Sasieni P, Bellenguez C, Howarth K, Freeman C, Trudgill N, Tucker AT, Pirinen M, Peppelenbosch MP, van der Laan LJ, Kuipers EJ, Drenth JP, Peters WH, Reynolds JV, Kelleher DP, McManus R, Grabsch H, Prenen H, Bisschops R, Krishnadath K, Siersema PD, van Baal JW, Middleton M, Petty R, Gillies R, Burch N, Bhandari P, Paterson S, Edwards C, Penman I, Vaidya K, Ang Y, Murray I, Patel P, Ye W, Mullins P, Wu AH, Bird NC, Dallal H, Shaheen NJ, Murray LJ, Koss K, Bernstein L, Romero Y, Hardie LJ, Zhang R, Winter H, Corley DA, Panter S, Risch HA, Reid BJ, Sargeant I, Gammon MD, Smart H, Dhar A, McMurtry H, Ali H, Liu G, Casson AG, Chow WH, Rutter M, Tawil A, Morris D, Nwokolo C, Isaacs P, Rodgers C, Ragunath K, MacDonald C, Haigh C, Monk D, Davies G, Wajed S, Johnston D, Gibbons M, Cullen S, Church N, Langley R, Griffin M, Alderson D, Deloukas P, Hunt SE, Gray E, Dronov S, Potter SC, Tashakkori-Ghanbaria A, Anderson M, Brooks C, Blackwell JM, Bramon E, Brown MA, Casas JP, Corvin A, Duncanson A, Markus HS, Mathew CG, Palmer CN, Plomin R, Rautanen A, Sawcer SJ, Trembath RC, Viswanathan AC, Wood N, Trynka G, Wijmenga C, Cazier JB, Atherfold P, Nicholson AM, Gellatly NL, Glancy D, Cooper SC, Cunningham D, Lind T, Hapeshi J, Ferry D, Rathbone B, Brown J, Love S, Attwood S, MacGregor S, Watson P, Sanders S, Ek W, Harrison RF, Moayyedi P, de Caestecker J, Barr H, Stupka E, Vaughan TL, Peltonen L, Spencer CC, Tomlinson I, Donnelly P, Jankowski JA. Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. Nat Genet. 2012 Oct; 44(10):1131-6. PMID: 22961001.
      View in: PubMed
    138. Sharma P, Savides TJ, Canto MI, Corley DA, Falk GW, Goldblum JR, Wang KK, Wallace MB, Wolfsen HC. The American Society for Gastrointestinal Endoscopy PIVI (Preservation and Incorporation of Valuable Endoscopic Innovations) on imaging in Barrett's Esophagus. Gastrointest Endosc. 2012 Aug; 76(2):252-4. PMID: 22817781.
      View in: PubMed
    139. Bergman JJGHM, Corley DA. Barrett's esophagus: who should receive ablation and how can we get the best results? Gastroenterology. 2012 Sep; 143(3):524-526. PMID: 22841734.
      View in: PubMed
    140. Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Weinberg DS, Della'Zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ. A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus. Gastroenterology. 2012 Oct; 143(4):917-26.e1. PMID: 22796132.
      View in: PubMed
    141. Parekh J, Corley DA, Feng S. Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation. Am J Transplant. 2012 Aug; 12(8):2181-7. PMID: 22548965.
      View in: PubMed
    142. Bennett C, Vakil N, Bergman J, Harrison R, Odze R, Vieth M, Sanders S, Gay L, Pech O, Longcroft-Wheaton G, Romero Y, Inadomi J, Tack J, Corley DA, Manner H, Green S, Al Dulaimi D, Ali H, Allum B, Anderson M, Curtis H, Falk G, Fennerty MB, Fullarton G, Krishnadath K, Meltzer SJ, Armstrong D, Ganz R, Cengia G, Going JJ, Goldblum J, Gordon C, Grabsch H, Haigh C, Hongo M, Johnston D, Forbes-Young R, Kay E, Kaye P, Lerut T, Lovat LB, Lundell L, Mairs P, Shimoda T, Spechler S, Sontag S, Malfertheiner P, Murray I, Nanji M, Poller D, Ragunath K, Regula J, Cestari R, Shepherd N, Singh R, Stein HJ, Talley NJ, Galmiche JP, Tham TC, Watson P, Yerian L, Rugge M, Rice TW, Hart J, Gittens S, Hewin D, Hochberger J, Kahrilas P, Preston S, Sampliner R, Sharma P, Stuart R, Wang K, Waxman I, Abley C, Loft D, Penman I, Shaheen NJ, Chak A, Davies G, Dunn L, Falck-Ytter Y, Decaestecker J, Bhandari P, Ell C, Griffin SM, Attwood S, Barr H, Allen J, Ferguson MK, Moayyedi P, Jankowski JA. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology. 2012 Aug; 143(2):336-46. PMID: 22537613.
      View in: PubMed
    143. Lubin JH, Cook MB, Pandeya N, Vaughan TL, Abnet CC, Giffen C, Webb PM, Murray LJ, Casson AG, Risch HA, Ye W, Kamangar F, Bernstein L, Sharp L, Nyrén O, Gammon MD, Corley DA, Wu AH, Brown LM, Chow WH, Ward MH, Freedman ND, Whiteman DC. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett's Esophagus and Esophageal Adenocarcinoma Consortium. Cancer Epidemiol. 2012 Jun; 36(3):306-16. PMID: 22504051.
      View in: PubMed
    144. Chuang KI, Corley D, Postlethwaite DA, Merchant M, Harris HW. Does increased experience with laparoscopic cholecystectomy yield more complex bile duct injuries? Am J Surg. 2012 Apr; 203(4):480-7. PMID: 22326050.
      View in: PubMed
    145. Cook MB, Shaheen NJ, Anderson LA, Giffen C, Chow WH, Vaughan TL, Whiteman DC, Corley DA. Cigarette smoking increases risk of Barrett's esophagus: an analysis of the Barrett's and Esophageal Adenocarcinoma Consortium. Gastroenterology. 2012 Apr; 142(4):744-53. PMID: 22245667.
      View in: PubMed
    146. Liao LM, Vaughan TL, Corley DA, Cook MB, Casson AG, Kamangar F, Abnet CC, Risch HA, Giffen C, Freedman ND, Chow WH, Sadeghi S, Pandeya N, Whiteman DC, Murray LJ, Bernstein L, Gammon MD, Wu AH. Nonsteroidal anti-inflammatory drug use reduces risk of adenocarcinomas of the esophagus and esophagogastric junction in a pooled analysis. Gastroenterology. 2012 Mar; 142(3):442-452.e5; quiz e22-3. PMID: 22108196.
      View in: PubMed
    147. Corley DA. The future of colon cancer screening: what do we recommend and will it be too much, too little, or just right? Gastroenterology. 2011 Dec; 141(6):1956-8. PMID: 22024535.
      View in: PubMed
    148. Yuhara H, Steinmaus C, Cohen SE, Corley DA, Tei Y, Buffler PA. Is diabetes mellitus an independent risk factor for colon cancer and rectal cancer? Am J Gastroenterol. 2011 Nov; 106(11):1911-21; quiz 1922. PMID: 21912438; PMCID: PMC3741453.
    149. Corley DA, Jensen CD, Marks AR. Can we improve adenoma detection rates? A systematic review of intervention studies. Gastrointest Endosc. 2011 Sep; 74(3):656-65. PMID: 21741643.
      View in: PubMed
    150. Corley DA. Understanding cancer incidence in Barrett's esophagus: light at the end of the tunnel. J Natl Cancer Inst. 2011 Jul 06; 103(13):994-5. PMID: 21680911.
      View in: PubMed
    151. Freedman ND, Murray LJ, Kamangar F, Abnet CC, Cook MB, Nyrén O, Ye W, Wu AH, Bernstein L, Brown LM, Ward MH, Pandeya N, Green AC, Casson AG, Giffen C, Risch HA, Gammon MD, Chow WH, Vaughan TL, Corley DA, Whiteman DC. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut. 2011 Aug; 60(8):1029-37. PMID: 21406386; PMCID: PMC3439838.
    152. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, Brown LM, Risch HA, Ye W, Sharp L, Pandeya N, Webb PM, Wu AH, Ward MH, Giffen C, Casson AG, Abnet CC, Murray LJ, Corley DA, Nyrén O, Vaughan TL, Chow WH. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010 Sep 08; 102(17):1344-53. PMID: 20716718.
      View in: PubMed
    153. Kubo A, Corley DA, Jensen CD, Kaur R. Dietary factors and the risks of oesophageal adenocarcinoma and Barrett's oesophagus. Nutr Res Rev. 2010 Dec; 23(2):230-46. PMID: 20624335; PMCID: PMC3062915.
    154. Cronin-Fenton DP, Murray LJ, Whiteman DC, Cardwell C, Webb PM, Jordan SJ, Corley DA, Sharp L, Lagergren J. Reproductive and sex hormonal factors and oesophageal and gastric junction adenocarcinoma: a pooled analysis. Eur J Cancer. 2010 Jul; 46(11):2067-76. PMID: 20456945.
      View in: PubMed
    155. Corley DA, Kubo A, Zhao W, Quesenberry C. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients. Gastroenterology. 2010 Jul; 139(1):93-101. PMID: 20353792; PMCID: PMC2902649.
    156. Corley DA. Chemoprevention in Barrett's esophagus: are we there yet, are we there yet...? Clin Gastroenterol Hepatol. 2009 Dec; 7(12):1266-8. PMID: 19772949; PMCID: PMC2789912.
    157. Corley DA, Kubo A, DeBoer J, Rumore GJ. Diagnosing Barrett's esophagus: reliability of clinical and pathologic diagnoses. Gastrointest Endosc. 2009 May; 69(6):1004-10. PMID: 19152897; PMCID: PMC2677140.
    158. Wong RJ, Corley DA. Survival differences by race/ethnicity and treatment for localized hepatocellular carcinoma within the United States. Dig Dis Sci. 2009 Sep; 54(9):2031-9. PMID: 19117131; PMCID: PMC2715467.
    159. Kubo A, Block G, Quesenberry CP, Buffler P, Corley DA. Effects of dietary fiber, fats, and meat intakes on the risk of Barrett's esophagus. Nutr Cancer. 2009; 61(5):607-16. PMID: 19838934; PMCID: PMC2765669.
    160. Kubo A, Levin TR, Block G, Rumore GJ, Quesenberry CP, Buffler P, Corley DA. Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus. Gastroenterology. 2009 Mar; 136(3):806-15. PMID: 19111726; PMCID: PMC2675884.
    161. Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, Quesenberry C, Buffler P. Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 1994-2006. Gut. 2009 Feb; 58(2):182-8. PMID: 18978173; PMCID: PMC2671084.
    162. Kubo A, Levin TR, Block G, Rumore G, Quesenberry CP, Buffler P, Corley DA. Cigarette smoking and the risk of Barrett's esophagus. Cancer Causes Control. 2009 Apr; 20(3):303-11. PMID: 18853262; PMCID: PMC2649684.
    163. Corley DA, Kubo A, Levin TR, Habel L, Zhao W, Leighton P, Rumore G, Quesenberry C, Buffler P, Block G. Iron intake and body iron stores as risk factors for Barrett's esophagus: a community-based study. Am J Gastroenterol. 2008 Dec; 103(12):2997-3004. PMID: 18853987; PMCID: PMC2671068.
    164. Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore G, Quesenberry C, Buffler P, Parsonnet J. Helicobacter pylori and gastroesophageal reflux disease: a case-control study. Helicobacter. 2008 Oct; 13(5):352-60. PMID: 19250510; PMCID: PMC2714194.
    165. Kubo A, Levin TR, Block G, Rumore GJ, Quesenberry CP, Buffler P, Corley DA. Dietary antioxidants, fruits, and vegetables and the risk of Barrett's esophagus. Am J Gastroenterol. 2008 Jul; 103(7):1614-23; quiz 1624. PMID: 18494834; PMCID: PMC2735568.
    166. Wong R, Corley DA. Racial and ethnic variations in hepatocellular carcinoma incidence within the United States. Am J Med. 2008 Jun; 121(6):525-31. PMID: 18501235.
      View in: PubMed
    167. Corley DA, Kubo A, Levin TR, Block G, Habel L, Rumore GJ, Quesenberry C, Buffler P. Hemochromatosis gene status as a risk factor for Barrett's esophagus. Dig Dis Sci. 2008 Dec; 53(12):3095-102. PMID: 18470614; PMCID: PMC2670929.
    168. Corley DA. Cancer incidence in Barrett's esophagus: does it really matter, and who's counting anyway? Gastrointest Endosc. 2008 Mar; 67(3):399-401. PMID: 18294502.
      View in: PubMed
    169. Douglas C. Current surveillance and therapeutic options for barrett esophagus. Gastroenterol Hepatol (N Y). 2008 Mar; 4(3):183-6. PMID: 21904494; PMCID: PMC3088295.
    170. Corley DA, Kubo A, Zhao W. Abdominal obesity and the risk of esophageal and gastric cardia carcinomas. Cancer Epidemiol Biomarkers Prev. 2008 Feb; 17(2):352-8. PMID: 18268119; PMCID: PMC2670999.
    171. Kubo A, Levin TR, Block G, Rumore GJ, Quesenberry CP, Buffler P, Corley DA. Dietary patterns and the risk of Barrett's esophagus. Am J Epidemiol. 2008 Apr 01; 167(7):839-46. PMID: 18218607.
      View in: PubMed
    172. Corley DA. Obesity and the rising incidence of oesophageal and gastric adenocarcinoma: what is the link? Gut. 2007 Nov; 56(11):1493-4. PMID: 17938426; PMCID: PMC2095675.
    173. Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Rumore G, Quesenberry C, Buffler P, Parsonnet J. Helicobacter pylori infection and the risk of Barrett's oesophagus: a community-based study. Gut. 2008 Jun; 57(6):727-33. PMID: 17895354; PMCID: PMC2670583.
    174. Mahadevan U, Sandborn WJ, Li DK, Hakimian S, Kane S, Corley DA. Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology. 2007 Oct; 133(4):1106-12. PMID: 17764676.
      View in: PubMed
    175. Kubo A, Corley DA. Meta-analysis of antioxidant intake and the risk of esophageal and gastric cardia adenocarcinoma. Am J Gastroenterol. 2007 Oct; 102(10):2323-30; quiz 2331. PMID: 17581269.
      View in: PubMed
    176. Corley DA, Kubo A, Levin TR, Block G, Habel L, Zhao W, Leighton P, Quesenberry C, Rumore GJ, Buffler PA. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology. 2007 Jul; 133(1):34-41; quiz 311. PMID: 17631128.
      View in: PubMed
    177. de Martel C, Haggerty TD, Corley DA, Vogelman JH, Orentreich N, Parsonnet J. Serum ghrelin levels and risk of subsequent adenocarcinoma of the esophagus. Am J Gastroenterol. 2007 Jun; 102(6):1166-72. PMID: 17378911.
      View in: PubMed
    178. Corley DA, Kubo A, Zhao W. Abdominal obesity, ethnicity and gastro-oesophageal reflux symptoms. Gut. 2007 Jun; 56(6):756-62. PMID: 17047097; PMCID: PMC1954862.
    179. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Gastroenterol. 2006 Nov; 101(11):2619-28. PMID: 16952280.
      View in: PubMed
    180. Gupta S, Vittinghoff E, Bertenthal D, Corley D, Shen H, Walter LC, McQuaid K. New-onset diabetes and pancreatic cancer. Clin Gastroenterol Hepatol. 2006 Nov; 4(11):1366-72; quiz 1301. PMID: 16945591.
      View in: PubMed
    181. Corley DA, Levin TR, Habel LA, Buffler PA. Barrett's esophagus and medications that relax the lower esophageal sphincter. Am J Gastroenterol. 2006 May; 101(5):937-44. PMID: 16573773.
      View in: PubMed
    182. Kubo A, Corley DA. Body mass index and adenocarcinomas of the esophagus or gastric cardia: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):872-8. PMID: 16702363.
      View in: PubMed
    183. de Martel C, Llosa AE, Farr SM, Friedman GD, Vogelman JH, Orentreich N, Corley DA, Parsonnet J. Helicobacter pylori infection and the risk of development of esophageal adenocarcinoma. J Infect Dis. 2005 Mar 01; 191(5):761-7. PMID: 15688293.
      View in: PubMed
    184. Corley DA, Kubo A. Influence of site classification on cancer incidence rates: an analysis of gastric cardia carcinomas. J Natl Cancer Inst. 2004 Sep 15; 96(18):1383-7. PMID: 15367571.
      View in: PubMed
    185. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, Cameron A, Corley D, Falk G, Goldblum J, Hunter J, Jankowski J, Lundell L, Reid B, Shaheen NJ, Sonnenberg A, Wang K, Weinstein W. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology. 2004 Jul; 127(1):310-30. PMID: 15236196.
      View in: PubMed
    186. Kubo A, Corley DA. Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol. 2004 Apr; 99(4):582-8. PMID: 15089886.
      View in: PubMed
    187. Corley DA, Katz P, Wo JM, Stefan A, Patti M, Rothstein R, Edmundowicz S, Kline M, Mason R, Wolfe MM. Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 2003 Sep; 125(3):668-76. PMID: 12949712.
      View in: PubMed
    188. Verma R, Corley DA. How should we select health professionals for studies? Outcomes Manag. 2003 Jul-Sep; 7(3):129-33. PMID: 12892047.
      View in: PubMed
    189. Corley DA, Kerlikowske K, Verma R, Buffler P. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis. Gastroenterology. 2003 Jan; 124(1):47-56. PMID: 12512029.
      View in: PubMed
    190. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer. 2002 Nov 15; 95(10):2096-102. PMID: 12412162.
      View in: PubMed
    191. Corley DA, Levin TR, Habel LA, Weiss NS, Buffler PA. Surveillance and survival in Barrett's adenocarcinomas: a population-based study. Gastroenterology. 2002 Mar; 122(3):633-40. PMID: 11874995.
      View in: PubMed
    192. Triadafilopoulos G, DiBaise JK, Nostrant TT, Stollman NH, Anderson PK, Wolfe MM, Rothstein RI, Wo JM, Corley DA, Patti MG, Antignano LV, Goff JS, Edmundowicz SA, Castell DO, Rabine JC, Kim MS, Utley DS. The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial. Gastrointest Endosc. 2002 Feb; 55(2):149-56. PMID: 11818914.
      View in: PubMed
    193. Corley DA, Buffler PA. Oesophageal and gastric cardia adenocarcinomas: analysis of regional variation using the Cancer Incidence in Five Continents database. Int J Epidemiol. 2001 Dec; 30(6):1415-25. PMID: 11821356.
      View in: PubMed
    194. Corley DA, Cello JP, Adkisson W, Ko WF, Kerlikowske K. Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology. 2001 Mar; 120(4):946-54. PMID: 11231948.
      View in: PubMed
    195. Corley DA, Cello JP, Koch J. Accuracy of endoscopic databases for assessing patient symptoms: comparison with self-reported questionnaires in patients infected with the human immunodeficiency virus. Gastrointest Endosc. 2000 Feb; 51(2):129-33. PMID: 10650252.
      View in: PubMed
    196. Corley DA, Cello JP, Koch J. Evaluation of upper gastrointestinal tract symptoms in patients infected with HIV. Am J Gastroenterol. 1999 Oct; 94(10):2890-6. PMID: 10520839.
      View in: PubMed
    197. Corley DA, Stefan AM, Wolf M, Cook EF, Lee TH. Early indicators of prognosis in upper gastrointestinal hemorrhage. Am J Gastroenterol. 1998 Mar; 93(3):336-40. PMID: 9517635.
      View in: PubMed
    198. Corley DA, Lindeman N, Ostroff JW. Survival with early diagnosis of invasive gastric mucormycosis in a heart transplant patient. Gastrointest Endosc. 1997 Nov; 46(5):452-4. PMID: 9402122.
      View in: PubMed
    199. Corley DA, Scharschmidt B, Bass N, Somberg K, Gold W, Sonnenberg K. Lack of efficacy of TIPS for hepatopulmonary syndrome. Gastroenterology. 1997 Aug; 113(2):728-30. PMID: 9247498.
      View in: PubMed
    200. Corley DA, Uyeki TM, Cello JP. Gastrointestinal bleeding and gastric outlet obstruction from Peutz-Jeghers polyposis. Diagnosis and treatment. West J Med. 1997 May; 166(5):350-2. PMID: 9217445; PMCID: PMC1304240.
    201. Corley D, Rowe J, Curtis MT, Hogan WM, Noumoff JS, Livolsi VA. Postmenopausal bleeding from unusual endometrial polyps in women on chronic tamoxifen therapy. Obstet Gynecol. 1992 Jan; 79(1):111-6. PMID: 1727568.
      View in: PubMed
    Corley's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    © 2019 Kaiser Permanente

    KP Researcher Profiles is funded by Kaiser Permanente Research.